EUVIMEDEUVIMED entdecken
Crossref

An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population

Sze Kei Liu iD, Han Cao iD, Xin Yang iD, Xiaopu Zhou iD, Yu Chen iD, Wing-Yu Fu, San Yuen Chan iD, Fanny Cf Ip iD, Kin Y Mok iD, Vincent Ct Mok iD, Timothy Cy Kwok iD, John Hardy iD und 2 weitere

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251350722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Sze Kei Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and T…. Hauptthemen laut MEDLINE: Alzheimer Disease, ATP Binding Cassette Transporter 1, Cholesterol, Genetic Predisposition to Disease. Die Arbeit nennt 54 Literaturangaben. Gefördert von: NSFC-RGC Joint Research Scheme, the Research Grants Council of Hong Kong, the Areas of Excellence Scheme of the University Grants Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genetic studies have revealed that single-nucleotide polymorphisms (SNPs) of ABCA1 are associated with Alzheimer's disease (AD) risk. However, their AD-related effects in non-European populations are not well studied. Moreover, the functional implications of these AD-associated SNPs remain unclear.

Objective

We examined the AD associations of ABCA1 SNPs in the Chinese population and investigated the underlying mechanisms whereby these SNPs modulate AD risk.

Methods

We conducted a genetic analysis in a Hong Kong Chinese AD cohort ( n = 332 patients with AD, n = 316 normal controls). Specifically, we analyzed 6 independent ABCA1 SNPs reported to be associated with AD risk in populations of European descent. To investigate the effects of these SNPs on ABCA1 protein function and brain molecular phenotypes, we analyzed cholesterol efflux in human glioblastoma cells as well as the associations between the AD risk SNPs and brain transcriptomic profiles, respectively.

Results

The ABCA1 coding SNP, rs2230806 (p.R219 K), was significantly associated with AD in the Chinese population, specifically in females (odds ratio [95% confidence interval] = 1.65 [1.16–2.33]). Notably, human glioblastoma cells expressing the ABCA1 R219 K showed a 17% cholesterol efflux reduction ( p < 0.001). Moreover, ABCA1 rs2230806 was associated with changes in the expression of oligodendrocyte genes involved in myelination in the brain in females.

Conclusions

We identified a significant AD risk ABCA1 coding variant in the Chinese population and demonstrated its effects on cholesterol efflux and brain molecular phenotypes. These results shed light on the genetic basis whereby an ABCA1 genetic variant contributes to AD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseATP Binding Cassette Transporter 1CholesterolGenetic Predisposition to DiseaseMutation, MissenseAgedAged, 80 and overFemaleHumansMaleMiddle AgedBrainCell Line, TumorCohort StudiesHong KongPolymorphism, Single NucleotideEast Asian People

Stichwörter der Autor:innen

ABCA1Alzheimer's diseasegeneticsoligodendrocytestranscriptomic analysis

Substanzen

ABCA1 protein, humanATP Binding Cassette Transporter 1Cholesterol

Autor:innen und Institutionen

  • Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, HKSAR, China.
  • InnoHK Hong Kong Center for Neurodegenerative Diseases, HKSAR, China.
  • Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Shenzhen-Hong Kong Institute of Brain Science, HKUST Shenzhen Research Institute, Shenzhen, China.
  • The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • SIAT-HKUST Joint Laboratory for Brain Science, Shenzhen, China.
  • Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.

ORCID-Profile: Sze Kei Liu, Han Cao, Xin Yang, Xiaopu Zhou, Yu Chen, San Yuen Chan, Fanny Cf Ip, Kin Y Mok, Vincent Ct Mok, Timothy Cy Kwok, John Hardy, Amy Ky Fu, Nancy Y Ip

Förderung

  • NSFC-RGC Joint Research Scheme
  • the Research Grants Council of Hong Kong
  • the Areas of Excellence Scheme of the University Grants Committee
  • the Innovation and Technology Commission
  • Fundamental Research Program of Shenzhen Virtual University Park
  • the Guangdong-Hong Kong Joint Laboratory for Psychiatric Disorders

Zitieren

APA

Liu, S. K., Cao, H., Yang, X., Zhou, X., Chen, Y., Fu, W. Y., Chan, S. Y., Ip, F. C., Mok, K. Y., Mok, V. C., Kwok, T. C., Hardy, J., Fu, A. K., & Ip, N. Y. (2025). An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251350722

Vancouver

Liu SK, Cao H, Yang X, Zhou X, Chen Y, Fu WY, et al. An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251350722

BibTeX
@article{Liu2025,
  author = {Liu, Sze Kei and Cao, Han and Yang, Xin and Zhou, Xiaopu and Chen, Yu and Fu, Wing-Yu and Chan, San Yuen and Ip, Fanny Cf and Mok, Kin Y and Mok, Vincent Ct and Kwok, Timothy Cy and Hardy, John and Fu, Amy Ky and Ip, Nancy Y},
  title = {An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251350722}
}
Kostenlos starten →